Ken Buetow is a human genetics and genomics researcher who leverages computational tools to understand complex traits such as cancer, liver disease, and obesity. He currently serves as director of Computational Sciences and Informatics program for Complex Adaptive Systems at Arizona State University (CAS@ASU), is a professor in the School of Life Sciences in ASU’s College of Liberal Arts and Sciences; is the director of Center for Evolution and Medicine; and is director of bioinformatics and data management for the National Biomarker Development Alliance.
Professor Buetow previously served as the Founding Director of the Center for Biomedical Informatics and Information Technology within the National Institutes of Health’s National Cancer Institute.
Education
Ph.D. Human Genetics, University of Pittsburgh 1985
M.S. Human Genetics, University of Pittsburgh 1983
Abernethy A, Abrahams E, Barker A, Buetow K, Burkholder R, Dalton WS, Foti M, Frueh F, Gaynor RB, Kean M, Khan Z, Lessor T, Lichtenfeld JL, Mendelsohn J, van't Veer L. Turning the Tide Against Cancer Through Sustained Medical Innovation: The Pathway to Success. Clin Cancer Res (2014).
Chen QR, Hu Y, Yan C, Buetow K, Meerzaman D. Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival. PLoS One (0).
Meerzaman DM, Yan C, Edmonson MN, Schaefer CF, Clifford RJ, Dunn BK, Dong L, Finney RP, Cultraro CM, Hu Y, Yang Z, Nguyen CV, Kelley JM, Cai S, Zhang H, Zhang J, Wilson R, Messmer L, Chen QR, Chung YH, Kim JA, Park NH, Lyu MS, Song IH, Buetow KH. Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma (HCC). Cancer Genomics Proteomics (0).
Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, Jain R, Colen R, Rubin DL, Zinn PO, Hwang SN, Raghavan P, Hammoud DA, Scarpace LM, Mikkelsen T, Chen J, Gevaert O, Buetow K, Freymann J, Kirby J, Flanders AE, Wintermark M;. Addition of MR Imaging Features and Genetic Biomarkers Strengthens Glioblastoma Survival Prediction in TCGA Patients. J Neuroradiol (0).
Research Activity
Buetow,Kenneth H*. Phase II: A Multiple Sclerosis Patient-Powered Research Network. ACP(9/5/2015 - 9/4/2018).
Buetow,Kenneth H*. A Multiple Sclerosis Patient-Powered Research Network. ACP(3/1/2014 - 11/30/2015).
Buetow,Kenneth H*. Immune Simulator for in silico research relevant to immune-based oncology drug targets. BRISTOL-MYERS-SQUIBB CO(12/3/2013 - 12/2/2016).
